secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001493152-23-004296
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience shareholders elect seven directors, ratify auditor, approve exec compensation at annual meeting
--------------------------------------------------------------------------------

- All seven director nominees elected with between 96.60% and 99.19% of votes cast.
- Ratification of Weinberg & Company as auditor for FY ending July 31, 2023 approved with 99.87% of votes cast.
- Advisory approval of executive compensation passed with 96.84% of votes cast.
- Turnout of 59.23% of outstanding shares (65,965,992 of 111,356,485 shares) represented at the meeting.
- Broker non-votes totaled 11,742,927 shares on director elections and executive compensation proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223004296/0001493152-23-004296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223004296/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer